There are 10 news.
Bertin Bioreagents innovations displayed at the EUROTOX Congress 2018 | September 2-5, Brussels, BelgiumKnow more
Odile Viltart & Virginie Tolle, PhD, from the Psychiatry & Neurosciences Center in Paris, validated Bertin Bioreagent’s immunoassay kits by demonstrating the absence of immunoreactivity for both acyl & desacyl ghrelin in preproghrelin deficient mice…Know more
Bertin Pharma is acquired by Bertin Technologies on January 2018. The Bioreagent activity is now included into the Business Unit Systems & Instrumentation.Know more
On August 2017, Bertin Pharma has signed an agreement for the sale of its pre-clinical and clinical studies’ activities.Know more
Genetics alone don’t account for a patient’s age, history of diseases, personal habits or environmental exposure.Know more